Pharmaphobia
Rowman & Littlefield (Verlag)
978-1-4422-4462-7 (ISBN)
Pharmaphobia describes how an ideological crusade, stretching over the last quarter century, has used distortion and flawed logic to make medical innovation even harder in a misguided pursuit of theoretical professional purity. Bureaucrats, reporters, politicians, and predatory lawyers have built careers attacking the medical products industry, belittling its critical contributions to medical innovation and accusing it of non-existent malfeasance: overselling product value, flaunting safety and corrupting physicians and academics who partner with it. The mania has imposed “conflict-of-interest” regulations limiting or banning valuable interactions between industry and physicians and researchers and diverting scarce resources from innovation to compliance. The victims are patients suffering from cancer, dementia, and other serious diseases for which new treatments are delayed, reduced, or eliminated as a result of these pointless regulations. With breathtaking detail, Thomas Stossel shows how this attack on doctors who work with industry limits medical innovation and inhibits the process of bringing new products into medical care.
Thomas P. Stossel, M.D., is a hematologist and medical researcher at Boston’s Brigham & Women’s Hospital and Harvard Medical School, where he is the American Cancer Society Professor of Medicine. He has authored more than 290 publications and two textbooks, and is an inventor on 11 issued patents. He is an elected member of the National Academy of Sciences, the founder and scientific director of two biotechnology start-up companies, a cofounder - along with his wife Kerry Maguire, D.D.S., M.S.P.H. and others - of the medical outreach organization Options for Children in Zambia, and a Visiting Scholar at the American Enterprise Institute.
Introduction
Part I: Some Benefits and the Mechanics of Medical Innovation
Chapter 1: The Stakes
Chapter 2: A Practitioner’s History of Medical Innovation
Part II: Why We Have a Medical Innovation Crisis
Chapter 3: Enter the Conflict-of-Interest Mania
Chapter 4: The Mania Mongers
Part III: Why They Are Wrong
Chapter 5: Abusing Evidence
Chapter 6: Bad Policy Process
Chapter 7: Flawed and Damaging Policies
Chapter 8: Misunderstanding Innovation
Chapter 9: Economic Illiteracy
Chapter 10: Misplaced Criticism of Incremental Innovation
Chapter 11: Rushing to Judgment with Product Safety Alarms
Chapter 12: Demonizing Marketing is False Advertising
Chapter 13: The “Gift” Smoke Screen
Chapter 14: The Lawyers’ Ball
Part IV: The Damage They Do and How to Stop It
Chapter 15: The Price We Pay
Chapter 16: What Is To Be Done?
Verlagsort | Lanham, MD |
---|---|
Sprache | englisch |
Maße | 163 x 231 mm |
Gewicht | 653 g |
Themenwelt | Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie |
Medizin / Pharmazie ► Gesundheitswesen | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Medizinethik | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Pharmazie | |
Studium ► Querschnittsbereiche ► Prävention / Gesundheitsförderung | |
Technik | |
ISBN-10 | 1-4422-4462-3 / 1442244623 |
ISBN-13 | 978-1-4422-4462-7 / 9781442244627 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich